The Alliance of Community Health Plans (ACHP) submitted a letter to the Centers for Medicare & Medicaid Services (CMS) about the National Coverage Determination (NCD) for beta amyloid pet scans in dementia and neurodegenerative disease patients.
With promising but uncertain treatments of Alzheimer’s actively in development, testing and early usage, now is not the appropriate time to change an NCD that has been in place and working since 2013.
New from ACHP:
- ACHP Responds to RFI on the State of Artificial Intelligence in Health Care
- ACHP Urges HHS to Take Action to Prevent Future Cyberattacks
- Frequently Asked Questions on Broker Compensation Reform
- “Overcoming Barriers: Transforming Black Maternal Health Through Research” Webinar
- PODCAST: ACHP’s Ceci Connolly Joins Managed Healthcare Executive DC Roundtable Podcast
- OP-ED: What Could We Do if GLP-1 Weight Loss Drugs Were Free? Would Our Obesity Epidemic Be Solved for Good?